Abnormal PKR function has also been implicated in the pathophysiology of non-hereditary PVOD, a condition that arises from the utilization of chemotherapeutic compounds, including cisplatin, bleomycin, and mitomycin C (MMC) [145]. This evidence concerns the gene EIF2AK2 and pulmonary venoocclusive disease.